Price $34.57 |
Market Cap
695.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
75.0
|
P/B
4.28
|
P/S
12.21
|
Dividend %
0.70%
|
|
P/CF
121.9
|
P/FCF
45.4
|
Op. Cash Flow
21.9K
|
FCF
0.8
|
|
Op. Margin
13.50%
|
Net Margin
16.70%
|
ROE
5.80%
|
ROI
3.70%
|
|
ROA
5.50%
|
EPS Growth
-19.70%
|
Current Ratio
10.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| ZimVie Inc (ZIMV) | $16.93 | - | - | 197.4M | Strong Buy |
| Myomo Inc (MYO) | $3.77 | - | - | 35.8M | Strong Buy |
| Marizyme Inc (MRZM) | $0.03 | - | - | 8.6M | Strong Buy |
| Lexaria Bioscience Corp (LEXX) | $3.30 | - | - | 12.8M | Strong Buy |
| KORU Medical Systems Inc (KRMD) | $2.47 | - | - | 103.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
